Africa’s most populous nation, Nigeria reports over 1,000 cases of leprosy yearly, a disease caused by a bacterium, Mycobacterium leprae, and mainly affecting the skin, peripheral nerves, and eyes.
But Nigeria ran out of stock of the multi-drug therapy in early 2024 as a bureaucratic delay in supplies and new domestic testing regulations on imported medicines held up the drugs in India, where one of the components is made.



